Find psychiatry resources faster
Evidence prioritized, noise reduced
4Psychiatry is a focused search engine for psychiatry. We aggregate clinical guidelines, peer-reviewed research, patient resources, training materials, and vendor listings into a single, specialized index. Our ranking and AI systems prioritize clinical relevance and evidence quality to surface results that matter to psychiatrists, trainees, allied professionals, and informed patients. Use the web, news, shopping, and AI chat features to find answers, keep up with developments, and locate useful products and services. Part of the 4SEARCH network of topic specific search engines.
Latest News & Web Pages
Cantwell Celebrates Groundbreaking of New Integrated Behavioral Health Center in Downtown Spokane: Multifaceted Care "Under One Roof" " Van Nuys News Press
1+ hour, 42+ min ago (526+ words) Van Nuys News Press Cantwell Celebrates Groundbreaking of New Integrated Behavioral Health Center in Downtown Spokane: Multifaceted Care "Under One Roof" Sen. Cantwell secured a $2 million federal grant for the project, slated to open fall 2027 SPOKANE, WA " Today, U. S. Senator Maria…...
Gauteng Health Department warns of rising youth psychosis linked to substance abuse
4+ hour, 25+ min ago (539+ words) As South Africa concludes Youth Month, the Gauteng Department of Health raises alarms over a troubling increase in substance-induced psychosis among the youth. As South Africa wraps up its annual Youth Month commemorations, the Gauteng Department of Health has issued…...
Parkinson's Drug shows promise in Fighting treatment-resistant depression
5+ hour, 58+ min ago (418+ words) ...
Clinicians cautious a year after psilocybin approved for patients
9+ hour, 10+ min ago (1057+ words) Just two doctors have Medsafe approval to write prescriptions for the psychedelic ingredient in magic mushrooms. (Source: 1 News) A year on since psilocybin was approved for private patient use, medical professionals remain cautious about the medicinal use of magic mushrooms…...
America is running out of therapists. Here's how primary care might have to fill the gap.
1+ day, 10+ min ago (158+ words) April Health reports America faces a therapist shortage, with 40% of the population lacking access to mental health care, prompting primary care to adapt and fill the gap. (alvarog1970 // Shutterstock/alvarog1970 // Shutterstock) Below, April Health examines this question in detail. Despite the evidence…...
A fourth pillar for evidence-based medicine: implications for psychiatry " CORRIGENDUM | The British Journal of Psychiatry
22+ hour, 13+ min ago (71+ words) Published online by Cambridge University Press:" 29 June 2026 This article originally published with an error in figure 1. The correct figure 1 is shown below. The four pillars of evidence-based medicine. The authors apologise for the error. Fig. 1 Fig. 1 long description. The four…...
Tonix Pharmaceuticals Enrolls First Patient in Phase 2 Trial of TNX-102 SL for Major Depressive Disorder
22+ hour, 34+ min ago (290+ words) citybuzz - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) announced that the first patient has been enrolled in the HORIZON Phase 2 clinical trial evaluating TNX-102 SL 5. 6 mg as a first-line monotherapy for adults with major depressive disorder (MDD). The randomized, double-blind, placebo-controlled study…...
Genetic analysis of active neurons finds stronger links to neuropsychiatric disorders
20+ hour, 50+ min ago (449+ words) A new genetic analysis of brain cells provides more clues about the functional effects of gene variants that are associated with neuropsychiatric disorders like schizophrenia. The study, a collaboration between scientists at the University of Chicago and Endeavor Health, measured…...
Exposure to violence contributes to high rates of suicidal thoughts and attempts among transgender people
1+ day, 2+ hour ago (17+ words) Phys. org...
Lithium MRI scans offer personalized treatments for bipolar disorder
1+ day, 44+ min ago (174+ words) A revolutionary scanning technique has revealed that lithium MRI is a powerful tool for studying how the drug interacts with the brain and could offer more personalized treatment for bipolar disorder. This paves the way for the for the medical…...